Author name: Claritas Rx

What metrics help government payers understand value and cost controls for rare disease therapies?

Comparing drug efficacy is essential — and backing it up with quantifiable data is a must.

To help patients adhere to treatment protocols, collect patient-level data.

Why do patients fail to adhere to treatment protocols? We explore the bevy of reasons for patient nonadherence and what can be done about it.

CMS’s value-based programs often look for lack: fewer infections, lower readmissions, etc. Here’s how to demonstrate non-events.

Spreadsheets are clunky and inefficient for contract tracking. Here’s how an automated platform solves those challenges.

Specialized patient data for rare disease research can be difficult to obtain. Here are the standard and emerging sources for researchers.

Rare disease researchers don’t always have the data they need for a long-term view. Here’s how teams can adapt.